Marex Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$400K Buy
1,800
+500
+38% +$116K ﹤0.01% 1268
2026
Q2
$309K Buy
+1,300
New +$270K ﹤0.01% 851
2026
Q1
– Sell
-1,500
Closed -$308K – 1046
2025
Q4
$308K Sell
1,500
-500
-25% -$94.1K ﹤0.01% 703
2025
Q3
$314K Buy
+2,000
New +$309K ﹤0.01% 613

Other funds holding CAH

Marex Group's CAH Position: Q3 2026 in Review

Marex Group opened a new position in Cardinal Health (CAH) in Q3 2026: 1,841 shares worth $410K. The stake represents ﹤0.01% of the portfolio and ranks #1256 among its holdings. This is a return to the name: Marex Group previously reported a position in CAH as recently as Q2 2024.

Marex Group first reported a position in CAH in Q4 2022 and has held it in 4 quarters since. The position peaked at $8.82M in Q4 2023. 1,496 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Marex Group held 1,841 shares of Cardinal Health worth $410K as of Q3 2026.
  • Cardinal Health was a new Marex Group position in Q3 2026.
  • Cardinal Health made up ﹤0.01% of Marex Group's portfolio in Q3 2026, its #1256 holding.
  • Marex Group first reported a position in Cardinal Health in Q4 2022 and has held it in 4 quarters since.
  • Marex Group's Cardinal Health position peaked at $8.82M in Q4 2023.
  • 1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Marex Group's 13F filing for Q3 2026, filed 16 Nov 2026.